Draft genome sequence of Acinetobacter pittii ST643 shared by cystic fibrosis patients
AUTOR(ES)
Rocha, Géssica A, Ferreira, Alex G, Lima, Danielle F, Leão, Robson S, Carvalho-Assef, Ana Paula D, Folescu, Tânia W, Albano, Rodolpho M, Marques, Elizabeth A
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
2016-09
RESUMO
Acinetobacter pittii has emerged as an important hospital pathogen that is associated with outbreaks and drug resistance. In cystic fibrosis (CF) patients, the detection of Acinetobacter spp. is rare; however, we isolated the A. pittii sequence type ST643 in several Brazilian CF patients treated in the same centre. The current study describes the draft genome of A. pittii ST643.
Documentos Relacionados
- Draft genome sequence of a multidrug-resistant beta-lactamase OXA-357-producing Acinetobacter pittii ST865 clinical isolate from China
- Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients
- Draft genome sequence of a multidrug-resistant Acinetobacter baumannii ST15 (CC15) isolated from Brazil
- Glimpse into the genome sequence of a multidrug-resistant Acinetobacter pittii ST950 clinical isolate carrying the blaOXA-72 and blaOXA-533 genes in China
- Draft genome sequence of phenol degrading Acinetobacter sp. Strain V2, isolated from oil contaminated soil
